Assembly Biosciences (ASMB) Shares Outstanding (2010 - 2026)

Assembly Biosciences' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $15.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 108.59% year-over-year to $15.9 million; the TTM figure through Mar 2026 stood at $15.9 million (up 108.59% YoY), while the FY2025 annual figure was $11.2 million, up 86.71% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $15.9 million, up from $11.2 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $15.9 million in Q1 2026, with the low at $4.0 million in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $5.5 million (2023), against an average of $6.7 million.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) rose 1.61% in 2022, then surged 108.59% in 2026.
• Assembly Biosciences' Shares Outstanding (Entity) stood at $4.1 million in 2022, then surged by 34.57% to $5.5 million in 2023, then climbed by 9.52% to $6.0 million in 2024, then surged by 86.71% to $11.2 million in 2025, then surged by 41.76% to $15.9 million in 2026.
• Business Quant data shows ASMB's Shares Outstanding (Entity) at $15.9 million in Q1 2026, $11.2 million in Q4 2025, and $12.7 million in Q3 2025.